| Ident. | Authors (with country if any) | Title |
|---|
| 000A09 (2018) |
Brian L. Venables [États-Unis] ; Ny Sin [États-Unis] ; Alan Xiangdong Wang [États-Unis] ; Li-Qiang Sun [États-Unis] ; Yong Tu [États-Unis] ; Dennis Hernandez [États-Unis] ; Amy Sheaffer [États-Unis] ; Min Lee [États-Unis] ; Cindy Dunaj [États-Unis] ; Guangzhi Zhai [États-Unis] ; Diana Barry [États-Unis] ; Jacques Friborg [États-Unis] ; Fei Yu [États-Unis] ; Jay Knipe [États-Unis] ; Jason Sandquist [États-Unis] ; Paul Falk [États-Unis] ; Dawn Parker [États-Unis] ; Andrew C. Good [États-Unis] ; Ramkumar Rajamani [États-Unis] ; Fiona Mcphee [États-Unis] ; Nicholas A. Meanwell [États-Unis] ; Paul M. Scola [États-Unis] | P3-P4 ureas and reverse carbamates as potent HCV NS3 protease inhibitors: Effective transposition of the P4 hydrogen bond donor. |
| 000C81 (2016) |
Sheng Liu [République populaire de Chine] ; Yubin Li [République populaire de Chine] ; Wanxing Wei [République populaire de Chine] ; Kuiwu Wang [République populaire de Chine] ; Lisheng Wang [République populaire de Chine] ; Jianyi Wang [République populaire de Chine] | Design, synthesis, molecular docking studies and anti-HBV activity of phenylpropanoid derivatives. |
| 000D52 (2015) |
Aidang Lu [République populaire de Chine] ; Yuanyuan Ma [République populaire de Chine] ; Ziwen Wang [République populaire de Chine] ; Zhenghong Zhou [République populaire de Chine] ; Qingmin Wang [République populaire de Chine] | Application of "Hydrogen-Bonding Interaction" in Drug Design. Part 2: Design, Synthesis, and Structure-Activity Relationships of Thiophosphoramide Derivatives as Novel Antiviral and Antifungal Agents. |
| 000D80 (2015) |
Lyudmyla G. Glushakova [États-Unis] ; Nidhi Sharma [États-Unis] ; Shuichi Hoshika [États-Unis] ; Andrea C. Bradley [États-Unis] ; Kevin M. Bradley [États-Unis] ; Zunyi Yang [États-Unis] ; Steven A. Benner [États-Unis] | Detecting respiratory viral RNA using expanded genetic alphabets and self-avoiding DNA. |
| 000D84 (2015) |
Wenxin Li [République populaire de Chine] ; Xiao Li [République populaire de Chine] ; Erik De Clercq [Belgique] ; Peng Zhan [République populaire de Chine] ; Xinyong Liu [République populaire de Chine] | Discovery of potent HIV-1 non-nucleoside reverse transcriptase inhibitors from arylthioacetanilide structural motif. |
| 000E70 (2015) |
Aidang Lu [République populaire de Chine] ; Ziwen Wang ; Zhenghong Zhou ; Jianxin Chen ; Qingmin Wang | Application of "hydrogen bonding interaction" in new drug development: design, synthesis, antiviral activity, and SARs of thiourea derivatives. |
| 001274 (2013) |
Sho Konno [Japon] ; Pillaiyar Thanigaimalai ; Takehito Yamamoto ; Kiyohiko Nakada ; Rie Kakiuchi ; Kentaro Takayama ; Yuri Yamazaki ; Fumika Yakushiji ; Kenichi Akaji ; Yoshiaki Kiso ; Yuko Kawasaki ; Shen-En Chen ; Ernesto Freire ; Yoshio Hayashi | Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety. |
| 001580 (2011) |
Zai Wang [République populaire de Chine] ; Jian-Dong Huang ; Kin-Ling Wong ; Pei-Gang Wang ; Hao-Jie Zhang ; Julian A. Tanner ; Ottavia Spiga ; Andrea Bernini ; Bo-Jian Zheng ; Neri Niccolai | On the mechanisms of bananin activity against severe acute respiratory syndrome coronavirus. |
| 001628 (2010) |
Jun Liu [République populaire de Chine] ; Peng Wu ; Feng Gao ; Jianxun Qi ; Ai Kawana-Tachikawa ; Jing Xie ; Christopher J. Vavricka ; Aikichi Iwamoto ; Taisheng Li ; George F. Gao | Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein. |
| 001767 (2010) |
Yantao Chen [République populaire de Chine] ; Mingliang Wang ; Qianling Zhang ; Jianhong Liu | Construction of an implicit membrane environment for the lattice Monte Carlo simulation of transmembrane protein. |
| 001952 (2009) |
Krongsakda Phakthanakanok [Thaïlande] ; Khanok Ratanakhanokchai ; Khin Lay Kyu ; Pornthep Sompornpisut ; Aaron Watts ; Surapong Pinitglang | A computational analysis of SARS cysteine proteinase-octapeptide substrate interaction: implication for structure and active site binding mechanism. |
| 001A84 (2008) |
Veena Nukoolkarn [Thaïlande] ; Vannajan Sanghiran Lee ; Maturos Malaisree ; Ornjira Aruksakulwong ; Supot Hannongbua | Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL(pro) inhibitors. |
| 001B16 (2008) |
Alex G. Taranto [Brésil] ; Paulo Carvalho ; Mitchell A. Avery | QM/QM studies for Michael reaction in coronavirus main protease (3CL Pro). |
| 001B25 (2008) |
Gustav R Der [Danemark] ; Ole Kristensen ; Jette S. Kastrup ; S Ren Buus ; Michael Gajhede | Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501. |
| 001B94 (2008) |
Yi-Ming Shao [Taïwan] ; Wen-Bin Yang ; Tun-Hsun Kuo ; Keng-Chang Tsai ; Chun-Hung Lin ; An-Suei Yang ; Po-Huang Liang ; Chi-Huey Wong | Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease. |
| 001D38 (2007) |
Yi-Ming Shao [République populaire de Chine] ; Wen-Bin Yang ; Hung-Pin Peng ; Min-Feng Hsu ; Keng-Chang Tsai ; Tun-Hsun Kuo ; Andrew H-J Wang ; Po-Huang Liang ; Chun-Hung Lin ; An-Suei Yang ; Chi-Huey Wong | Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors. |
| 001D75 (2007) |
Jiang Yin [Canada] ; Chunying Niu ; Maia M. Cherney ; Jianmin Zhang ; Carly Huitema ; Lindsay D. Eltis ; John C. Vederas ; Michael N G. James | A mechanistic view of enzyme inhibition and peptide hydrolysis in the active site of the SARS-CoV 3C-like peptidase. |
| 001F96 (2007) |
Kewen Zheng [République populaire de Chine] ; Guozheng Ma ; Jinming Zhou ; Min Zen ; Wenna Zhao ; Yongjun Jiang ; Qingsen Yu ; Jialiang Feng | Insight into the activity of SARS main protease: Molecular dynamics study of dimeric and monomeric form of enzyme. |
| 002123 (2006) |
I-Lin Lu [République populaire de Chine] ; Neeraj Mahindroo ; Po-Huang Liang ; Yi-Hui Peng ; Chih-Jung Kuo ; Keng-Chang Tsai ; Hsing-Pang Hsieh ; Yu-Sheng Chao ; Su-Ying Wu | Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease. |
| 002145 (2006) |
Syaulan Yang [République populaire de Chine] ; Shu-Jen Chen ; Min-Feng Hsu ; Jen-Dar Wu ; Chien-Te K. Tseng ; Yu-Fan Liu ; Hua-Chien Chen ; Chun-Wei Kuo ; Chi-Shen Wu ; Li-Wen Chang ; Wen-Chang Chen ; Shao-Ying Liao ; Teng-Yuan Chang ; Hsin-Hui Hung ; Hui-Lin Shr ; Cheng-Yuan Liu ; Yu-An Huang ; Ling-Yin Chang ; Jen-Chi Hsu ; Clarence J. Peters ; Andrew H-J Wang ; Ming-Chu Hsu | Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor. |
| 002230 (2006) |
D-Q Wei [République populaire de Chine] ; R. Zhang ; Q-S Du ; W-N Gao ; Y. Li ; H. Gao ; S-Q Wang ; X. Zhang ; A-X Li ; S. Sirois ; K-C Chou | Anti-SARS drug screening by molecular docking. |
